Skip to main content

Table 2 Content of baseline and follow-up questionnaires

From: Efficacy of moxibustion for pre- or stage I hypertension: study protocol for a pilot randomized controlled trial

Measures

Baseline

End of treatment

Follow-up

  

at 4 weeks after randomization

at 8, 12, 16, 20 and 24 weeks after randomization

Informed consent

x

-

-

Inclusion/exclusion criteria

x

-

-

Randomization

x

-

-

Demographic information taking

x

-

-

Blood pressure

x

x

x

Blood test

x

x

-

General assessment

-

x

-

BMI (body mass index)

x

x

x

NDI (neck disability index)

x

x

x

EQ-5D (EuroQol)

x

x

x

PSQI (Pittsburgh Sleep Quality Index)

x

x

x

HRV (heart rate variability)

x

x

x

Questionnaire of pattern identification

x

x

x

SRI-MF (modified form of the Stress Response Inventory)

x

x

x

FSS (Fatigue Severity Scale)

x

x

x

Adverse events

-

x

x